LAWRENCE, Mass.—NxStage Medical and its Medisystems division have expanded its existing long-term product supply agreement with Renal Advantage to include the 43 facilities the dialysis provider acquired from National Renal Alliance.
As a result, NxStage will supply the Streamline airless blood tubing set, as well as MasterGuard needles and other products, to these additional facilities in RAI's dialysis center network.
"RAI has been a strong long-term customer of our Medisystems division, as well as a strategic partner with NxStage within the home hemodialysis market. We are extremely pleased that RAI is broadening its commitment to our products by integrating Streamline and MasterGuard into all of their in-center operations," said Jeffrey H. Burbank, president and chief executive officer of NxStage Medical. "We believe that our innovative technology and high quality product portfolio remain significant drivers for end user demand."
Brentwood, Tenn,-based Renal Advantage provides services to approximately 12,000 patients in 149 dialysis centers in 19 states.
"We are delighted to expand our relationship with NxStage to extend the benefits of Streamline and MasterGuard to our patients," said Dean Weiland, chief operations officer of RAI. "We originally implemented Streamline into 45 of our facilities. After reviewing the clinical and operational data we collected from those centers, we determined that the KT/V improvement, operational cost savings and staff satisfaction were significant and validated the standardization of Streamline across all of facilities we acquired from National Renal Alliance. We believe that Streamline helps to position our facilities for clinical and operational excellence as we prepare for 'bundled' reimbursement."
